Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Boehringer Selects Certara’s Drug Discovery Platform | Contract Pharma

What are you searching for?

Sign in
Breaking News

Boehringer Selects Certara’s Drug Discovery Platform

Provides shared discovery data across global working groups

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Boehringer Ingelheim has selected Certara’s D360 as its global drug discovery platform. D360 is an integrated solution for the query, analysis and visualization of drug discovery and development data. It will allow Boehringer to share discovery data across global working groups, including external collaborators. Boehringer plans to install the global data mining tool at three sites, Ridgefield, CT, Biberach, Germany, and Vienna, Austria.
 
“In addition to integrating data for easy access, D360 empowers researchers to query and analyze their data without support from the IT team,” said Jonathan Feldmann, vice president of scientific informatics at Certara. “D360 enables researchers to quickly answer their questions as they conceive them, thus helping to shorten the drug discovery cycle.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics